---
document_datetime: 2025-10-21 11:02:38
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/praluent-epar-all-authorised-presentations_en.pdf
document_name: praluent-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.8922722
conversion_datetime: 2025-12-15 02:12:05.067316
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/15/1031/001   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen                                             | 1 ml (75 mg/ml)   | 1 pre-filled pen                      |
|--------------------|------------|---------|--------------------------|--------------------|------------------------------------------------------------------------------------------|-------------------|---------------------------------------|
| EU/1/15/1031/002   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen                                             | 1 ml (75 mg/ml)   | 2 pre-filled pens                     |
| EU/1/15/1031/003   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen                                             | 1 ml (75 mg/ml)   | 6 pre-filled pens                     |
| EU/1/15/1031/004   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass)                                                               | 1 ml (75 mg/ml)   | 1 pre-filled syringe                  |
| EU/1/15/1031/005   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass)                                                               | 1 ml (75 mg/ml)   | 2 pre-filled syringes                 |
| EU/1/15/1031/006   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass)                                                               | 1 ml (75 mg/ml)   | 6 pre-filled syringes                 |
| EU/1/15/1031/007   | Praluent   | 150 mg  | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen                                             | 1 ml (150 mg/ml)  | 1 pre-filled pen                      |
| EU/1/15/1031/008   | Praluent   | 150 mg  | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen                                             | 1 ml (150 mg/ml)  | 2 pre-filled pens                     |
| EU/1/15/1031/009   | Praluent   | 150 mg  | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen                                             | 1 ml (150 mg/ml)  | 6 pre-filled pens                     |
| EU/1/15/1031/010   | Praluent   | 150 mg  | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass)                                                               | 1 ml (150 mg/ml)  | 1 pre-filled syringe                  |
| EU/1/15/1031/011   | Praluent   | 150 mg  | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass)                                                               | 1 ml (150 mg/ml)  | 2 pre-filled syringes                 |
| EU/1/15/1031/012   | Praluent   | 150 mg  | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass)                                                               | 1 ml (150 mg/ml)  | 6 pre-filled syringes                 |
| EU/1/15/1031/013   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen without activation button                   | 1 ml (75 mg/ml)   | 1 pre-filled pen                      |
| EU/1/15/1031/014   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen without                                     | 1 ml (75 mg/ml)   | 2 pre-filled pens                     |
| EU/1/15/1031/015   | Praluent   | 75 mg   | Solution for injection   | Subcutaneous use   | activation button pre-filled syringe (glass) in pre-filled pen without activation button | 1 ml (75 mg/ml)   | 6 (2 x 3) pre-filled pens (multipack) |

<div style=\"page-break-after: always\"></div>

## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

| EU/1/15/1031/016   | Praluent   | 150 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen without                                     | 1 ml (150 mg/ml)   | 1 pre-filled pen                      |
|--------------------|------------|----------|--------------------------|--------------------|------------------------------------------------------------------------------------------|--------------------|---------------------------------------|
| EU/1/15/1031/017   | Praluent   | 150 mg   | Solution for injection   | Subcutaneous use   | activation button pre-filled syringe (glass) in pre-filled pen without                   | 1 ml (150 mg/ml)   | 2 pre-filled pens                     |
| EU/1/15/1031/018   | Praluent   | 150 mg   | Solution for injection   | Subcutaneous use   | activation button pre-filled syringe (glass) in pre-filled pen without                   | 1 ml (150 mg/ml)   | 6 (2 x 3) pre-filled pens (multipack) |
| EU/1/15/1031/019   | Praluent   | 300 mg   | Solution for injection   | Subcutaneous use   | activation button pre-filled syringe (glass) in pre-filled pen without activation button | 2 ml (150 mg/ml)   | 1 pre-filled pen                      |
| EU/1/15/1031/020   | Praluent   | 300 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen without activation button                   | 2 ml (150 mg/ml)   | 3 pre-filled pens                     |
| EU/1/15/1031/021   | Praluent   | 300 mg   | Solution for injection   | Subcutaneous use   | pre-filled syringe (glass) in pre-filled pen without activation button                   | 2 ml (150 mg/ml)   | 1 pre-filled pen                      |
| EU/1/15/1031/022   | Praluent   | 300 mg   | Solution for injection   | Subcutaneous use   | (ridged cap) pre-filled syringe (glass) in pre-filled pen without activation button      | 2 ml (150 mg/ml)   | 3 pre-filled pens                     |
| EU/1/15/1031/023   | Praluent   | 75 mg    | Solution for injection   | Subcutaneous use   | (ridged cap) pre-filled syringe (glass) in pre-filled pen without                        | 1 ml (75 mg/ml)    | 3 pre-filled pens                     |
| EU/1/15/1031/024   | Praluent   | 150 mg   | Solution for injection   | Subcutaneous use   | activation button pre-filled syringe (glass) in pre-filled pen without activation button | 1 ml (150 mg/ml)   | 3 pre-filled pens                     |